PL373607A1

Dna vaccines encoding cea and a cd40 ligand and methods of use thereof

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 28 February 2023, 3.6 years ago.

18 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims4

Priority claims
Document	Office	Kind	Date
9023802	United States of America	A	2002-03-02
9023802	United States of America	A	2002-03-02
0290238	–	–	–
US20020090238	–	–	–

Members18

Family members, oldest first
Document	Office	Kind
CA2477647A1	Canada	A1	2003-09-12
WO03074712A1	World Intellectual Property Organization (WIPO)	A1	2003-09-12
AU2003213653A1	Australia	A1	2003-09-16
US2003176377A1	United States of America	A1	2003-09-18
KR20040089696A	Republic of Korea	A	2004-10-21
MXPA04008475A	Mexico	A	2004-12-06
EP1487984A1	European Patent Office (EPO)	A1	2004-12-22
BR0308101A	Brazil	A	2005-01-04
RU2004129331A	Russian Federation	A	2005-04-20
US6923958B2	United States of America	B2	2005-08-02
CN1650015A	China	A	2005-08-03
PL373607A1This record	Poland	A1	2005-09-05
JP2005526750A	Japan	A	2005-09-08
EP1487984A4	European Patent Office (EPO)	A4	2005-11-30
US2005287123A1	United States of America	A1	2005-12-29
ZA200406991B	South Africa	B	2006-06-28
US7279464B2	United States of America	B2	2007-10-09
AU2003213653B2	Australia	B2	2007-11-15

1 legal event, as the office reported them to INPADOC

Events

Legal events, newest first
	Event	Code
2011-09-30	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)REFS	REFS